Shots: The P-II/III (SCORPIO-SR) trial evaluates Ensitrelvir (125/250mg) vs PBO in...
Shots: The 2nd P-III study evaluating safety & efficacy of VV116 (mindeudesivi...
Shots: The US FDA approved P-II IND evaluating silmitasertib (CX-4945) that aimed...
Shots: The European Patent Office declared that Moderna's mRNA patent was inva...
Shots: As per the agreement, Kogyo has the right to conduct preclinical & clin...
Shots: Fresenius Kabi has launched Tyenne, first tocilizumab biosimila...